Viatris launches Ryzumvi for mydriasis reversal
Viatris is launching Ryzumvi, the first FDA-approved eyedrop for reversing dilation, with…
Biogen, Eisai, Aardvark Therapeutics, etc.
Stay informed on the latest in biotech by signing up for the…
New gene discovery leads advance against a form of heart failure prevalent in men
University of Virginia School of Medicine researchers have identified a gene on…
Lancet study reveals alarming global obesity trends in 2022
A new study by the Lancet reveals that over 1 billion people…
How to Manage MS with Exercise and Eating Well
When Laura Wells was diagnosed with MS at 39, her focus on…
Full-Dose Beta-Lactam Allergy Challenges in ED
A study found that full-dose challenges of beta-lactam antibiotics in emergency department…
Tuberculosis Infection Linked To Increased Risk Of Various Cancers: Study
Tuberculosis (TB) is a deadly infectious disease that annually kills over a…
Last date for submission of annual declaration details by medical colleges extended: NMC
The National Medical Commission (NMC) has announced an extension for the submission…
AI Disruption is Coming. Are Healthcare Professionals Ready?
The artificial intelligence (AI) market is expected to exceed $400 billion by…
National Children’s Research Centre incorporated into Children’s Health Ireland
The National Children's Research Centre has been incorporated into Children's Health Ireland,…